Loading clinical trials...
Loading clinical trials...
Post-operative administration of ulimorelin is expected to reduce time to recovery of Gastrointestinal (GI) function in patients who have undergone partial large bowel resection.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Tranzyme, Inc.
Collaborators
Fountain Valley Regional Hospital
Fountain Valley, California
Orange Coast Memorial Med. Ctr.
Fountain Valley, California
USC, Colorectal Surgery Division
Los Angeles, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions